ATEC - Alphatec Holdings, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Carlsbad,
United States
Type: Equity
ATEC price evolution
ATEC
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $220.97 | $122.53 | $101.02 | $116.7 |
| Short term investments | ||||
| Net receivables | $72.61 | $64.52 | $59.93 | $62.41 |
| Inventory | $136.84 | $130.67 | $119.96 | $108.24 |
| Total current assets | $451.09 | $333.56 | $299.67 | $299.15 |
| Long term investments | ||||
| Property, plant & equipment | $176.25 | $160.87 | $146.79 | $137.81 |
| Goodwill & intangible assets | $175.45 | $173.75 | $178.03 | $129 |
| Total noncurrent assets | $354.12 | $336.66 | $328.57 | $270.54 |
| Total investments | ||||
| Total assets | $805.21 | $670.22 | $628.23 | $569.69 |
| Current liabilities | ||||
| Accounts payable | $48.98 | $50.1 | $43.7 | $39.07 |
| Deferred revenue | $13.91 | $13.83 | $13.89 | $13.94 |
| Short long term debt | $6.97 | $6.86 | $7.03 | $20.86 |
| Total current liabilities | $157.57 | $148.04 | $138.75 | $142.9 |
| Long term debt | $534.71 | $531.11 | $480.63 | $445.36 |
| Total noncurrent liabilities | $569.52 | $566.34 | $517.64 | $485.15 |
| Total debt | $541.68 | $537.97 | $487.66 | $466.23 |
| Total liabilities | $727.09 | $714.38 | $656.39 | $628.05 |
| Shareholders' equity | ||||
| Retained earnings | -$1118.96 | -$1069.88 | -$1027.23 | -$975.85 |
| Other shareholder equity | -$8.32 | -$12.11 | -$9.51 | -$9.69 |
| Total shareholder equity | $78.12 | -$44.16 | -$28.15 | -$58.36 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $220.97 | $84.7 | $187.25 | $107.77 |
| Short term investments | ||||
| Net receivables | $72.61 | $60.06 | $41.89 | $23.53 |
| Inventory | $136.84 | $101.52 | $91.7 | $46 |
| Total current assets | $451.09 | $255.63 | $331.16 | $184.16 |
| Long term investments | ||||
| Property, plant & equipment | $176.25 | $130.31 | $112.68 | $37.85 |
| Goodwill & intangible assets | $175.45 | $122.56 | $124.96 | $38.62 |
| Total noncurrent assets | $354.12 | $257.74 | $240.9 | $77.06 |
| Total investments | ||||
| Total assets | $805.21 | $513.38 | $572.05 | $261.22 |
| Current liabilities | ||||
| Accounts payable | $48.98 | $34.74 | $25.74 | $17.6 |
| Deferred revenue | $13.91 | $11.96 | ||
| Short long term debt | $6.97 | $19.79 | $4.55 | $5.08 |
| Total current liabilities | $157.57 | $138.87 | $101.09 | $58.31 |
| Long term debt | $534.71 | $349.51 | $350.87 | $38.08 |
| Total noncurrent liabilities | $569.52 | $411.22 | $391.54 | $73.03 |
| Total debt | $541.68 | $395.86 | $355.43 | $43.16 |
| Total liabilities | $727.09 | $526.49 | $492.63 | $131.34 |
| Shareholders' equity | ||||
| Retained earnings | -$1118.96 | -$934.47 | -$782.33 | -$638 |
| Other shareholder equity | -$8.32 | -$10.69 | -$5.99 | $1.2 |
| Total shareholder equity | $78.12 | -$36.71 | $79.42 | $129.88 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $137.97 | $118.26 | $116.92 | $109.11 |
| Cost of revenue | $42.78 | $38.22 | $52.38 | $38.69 |
| Gross Profit | $95.19 | $80.05 | $64.54 | $70.42 |
| Operating activities | ||||
| Research & development | $22.28 | $20 | $14.57 | $13.26 |
| Selling, general & administrative | $104.12 | $91.41 | $87.29 | $91.26 |
| Total operating expenses | $140.02 | $118.41 | $114.4 | $110.77 |
| Operating income | -$44.83 | -$38.36 | -$49.86 | -$40.35 |
| Income from continuing operations | ||||
| EBIT | -$44.79 | -$38.31 | -$47.53 | -$39.64 |
| Income tax expense | -$0.12 | -$0.12 | -$0.05 | $0.01 |
| Interest expense | $4.42 | $4.46 | $3.89 | $3.87 |
| Net income | ||||
| Net income | -$49.08 | -$42.65 | -$51.38 | -$43.53 |
| Income (for common shares) | -$49.08 | -$42.65 | -$51.38 | -$43.53 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $482.26 | $350.87 | $243.21 | $144.86 |
| Cost of revenue | $172.06 | $117.81 | $85.45 | $42.36 |
| Gross Profit | $310.2 | $233.06 | $157.76 | $102.5 |
| Operating activities | ||||
| Research & development | $70.11 | $44.03 | $32.02 | $18.75 |
| Selling, general & administrative | $374.08 | $300.01 | $229.27 | $129.16 |
| Total operating expenses | $483.6 | $380.03 | $285.82 | $161.36 |
| Operating income | -$173.4 | -$146.97 | -$128.06 | -$58.86 |
| Income from continuing operations | ||||
| EBIT | -$170.27 | -$146.5 | -$137.05 | -$66.47 |
| Income tax expense | -$0.28 | $0.14 | $0.16 | $0.14 |
| Interest expense | $16.64 | $5.5 | $7.11 | $12.37 |
| Net income | ||||
| Net income | -$186.64 | -$152.15 | -$144.33 | -$78.99 |
| Income (for common shares) | -$186.64 | -$152.15 | -$144.33 | -$78.99 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$49.08 | -$42.65 | -$51.38 | -$43.53 |
| Operating activities | ||||
| Depreciation | $16.96 | $15.65 | $14.54 | $12.52 |
| Business acquisitions & disposals | -$55 | |||
| Stock-based compensation | $20.52 | $20.07 | $24.19 | $16.46 |
| Total cash flows from operations | -$25 | -$17.29 | -$17.87 | -$18.32 |
| Investing activities | ||||
| Capital expenditures | -$25.72 | -$19.37 | -$19.14 | -$16.28 |
| Investments | ||||
| Total cash flows from investing | -$28.21 | -$21.38 | -$75.56 | -$16.82 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $147.02 | $9.13 | $57.07 | -$1.11 |
| Net borrowings | $3.67 | $52 | $21.53 | $69.14 |
| Total cash flows from financing | $151.57 | $60.33 | $77.91 | $67.11 |
| Effect of exchange rate | $0.09 | -$0.15 | -$0.16 | $0.03 |
| Change in cash and equivalents | $98.44 | $21.51 | -$15.68 | $32 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$186.64 | -$152.15 | -$144.33 | -$78.99 |
| Operating activities | ||||
| Depreciation | $59.68 | $43.93 | $30.17 | $11.63 |
| Business acquisitions & disposals | -$55 | -$83.23 | ||
| Stock-based compensation | $81.24 | $40.56 | $36.45 | $17.66 |
| Total cash flows from operations | -$78.48 | -$75.14 | -$73.43 | -$46.41 |
| Investing activities | ||||
| Capital expenditures | -$80.51 | -$49.45 | -$68.54 | -$23.1 |
| Investments | -$3 | |||
| Total cash flows from investing | -$141.97 | -$58.28 | -$157.76 | -$23.86 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $212.12 | -$3.04 | $100.86 | $111.04 |
| Net borrowings | $146.34 | $33.69 | $253.13 | $19.79 |
| Total cash flows from financing | $356.92 | $31.23 | $311.97 | $130.83 |
| Effect of exchange rate | -$0.18 | -$0.36 | -$1.29 | $0.09 |
| Change in cash and equivalents | $136.27 | -$102.55 | $79.48 | $60.65 |
News
Fundamentals
| Market cap | $1.82B |
|---|---|
| Enterprise value | $2.14B |
| Shares outstanding | 139.25M |
| Revenue | $482.26M |
|---|---|
| EBITDA | -$110.59M |
| EBIT | -$170.27M |
| Net Income | -$186.64M |
| Revenue Q/Q | 30.23% |
| Revenue Y/Y | N/A |
| P/E ratio | -9.77 |
|---|---|
| EV/Sales | 4.45 |
| EV/EBITDA | -19.39 |
| EV/EBIT | -12.60 |
| P/S ratio | 3.78 |
| P/B ratio | 21.10 |
| Book/Share | 0.62 |
| Cash/Share | 1.59 |
| EPS | -$1.34 |
|---|---|
| ROA | -27.93% |
| ROE | 1.42K% |
| Debt/Equity | 9.31 |
|---|---|
| Net debt/EBITDA | -4.58 |
| Current ratio | 2.86 |
| Quick ratio | 1.99 |